Call for Papers Trends in Immunotherapy Editor-in-Chief Prof. Dr. Fukumi Furukawa President Takatsuki Red Cross Hospital, Japan E-mail: ffurukawa@takatsuki.jrc.or.jp Associate Editors Prof. Hiroki Yamaue Wakayama Medical University Japan Prof. Toshikazu Kondo Wakayama Medical University Japan Indexing Trends in Immunotherapy has been indexed in such database as: Scopus, Google Scholar, Crossref, CNKI Scholar, Worldcat. Trends in Immunotherapy aims to be indexed by PubMed, ProQuest, MEDLINE and Science Citation Index (SCI). Key themes for submissions Key themes for submissions include but are not limited to: 1. Cancer immunotherapy 2. Targeted therapy and tumor microenvironment 3. Immune dysregulation, skin barrier dysfunction 4. Chemoimmunotherapy 5. Antibodies 6. Immunomodulators, inhibitors and intensifiers 7. Therapeutic method for auto-immune disorder 8. Efficacy of drug immunotherapy 9. Allergy disorder and immunotherapy 10. Immunotherapy cell-products 11. Immuno-modulatory effects of natural products 12. Vaccine development and application 13. Cytokines application 14. Wound healing TI publishes original research articles, review articles, editorials, mini-review articles, case reports, commentaries, correspondence articles, database articles, perspective articles, short reports, etc. Preliminary studies, pre-clinical and clinical investigative reports are welcomed. Submission Information Submission deadline: 30 November 2021 for Volume 5, 2021 All submissions must be made via Online Submissions. Please refer to the author guidelines before submitting. If you have any further queries, please contact the Guest Editors. Why US Trends in Immunotherapy is an open access, peer-reviewed journal encompassing various disciplines related to the immune-based therapeutic method. It was founded in 2017. After several years of hard work, the journal TI was accepted by Scopus in July 2021 under the leadership of the editor-in-chief and the cooperation of the editorial committee. EnPress Publisher LLC is an inclusive, progressive and professional publisher. Give us a chance to cooperate with each other. We will serve you well! |
This site is licensed under a Creative Commons Attribution 4.0 International License.